Seer (SEER) Long-Term Investments (2021 - 2026)
Seer (SEER) recorded quarterly Long-Term Investments of $52.8 million in Q1 2026, down 3.45% quarter-over-quarter from $54.7 million in Q4 2025, and up 15.84% on a YoY basis from $45.6 million in Q1 2025.
Seer (SEER) Long-Term Investments (2021 - 2026) Analysis & Trends
Seer's Long-Term Investments history runs 6 years deep, the most recent figure standing at $52.8 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 15.84% year-over-year to $52.8 million; the TTM figure through Mar 2026 stood at $52.8 million (up 15.84% YoY), while the FY2025 annual figure was $54.7 million, down 13.34% from the prior year.
- Long-Term Investments was $52.8 million for Q1 2026 at Seer, down from $54.7 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $75.8 million in Q2 2023 to a low of $4.9 million in Q3 2022.
- Historically, Long-Term Investments has averaged $45.9 million across 5 years, with a median of $52.8 million in 2026.
- The sharpest annual moves came in 2022 and 2023: Long-Term Investments sank 94.47% in 2022, then soared 1442.22% in 2023.
- A 5-year view of Long-Term Investments shows it stood at $5.2 million in 2022, then surged by 1002.54% to $56.9 million in 2023, then rose by 10.98% to $63.1 million in 2024, then dropped by 13.34% to $54.7 million in 2025, then dropped by 3.45% to $52.8 million in 2026.
- The last three Long-Term Investments figures came in at $52.8 million (Q1 2026), $54.7 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 52.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.80 Mn |
| Dec 31, 2025 | 54.69 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Jun 30, 2025 | 53.40 Mn |
| Mar 31, 2025 | 45.58 Mn |
| Dec 31, 2024 | 63.10 Mn |
| Sep 30, 2024 | 64.90 Mn |
| Jun 30, 2024 | 61.20 Mn |
| Mar 31, 2024 | 50.60 Mn |
| Dec 31, 2023 | 56.86 Mn |
| Sep 30, 2023 | 49.57 Mn |
| Jun 30, 2023 | 75.80 Mn |
| Mar 31, 2023 | 58.42 Mn |
| Dec 31, 2022 | 5.16 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 4.92 Mn |
| Mar 31, 2022 | 26.55 Mn |
| Dec 31, 2021 | 93.19 Mn |